The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Crizotinib in children and adolescents with advanced ROS1, MET, or ALK-rearranged cancer: Results of the AcSé phase II trial.
 
Gilles Vassal
Research Funding - Pfizer (Inst)
 
Laura Faivre
No Relationships to Disclose
 
Birgit Geoerger
No Relationships to Disclose
 
Dominique Plantaz
No Relationships to Disclose
 
Anne Auvrignon
No Relationships to Disclose
 
Carole Coze
No Relationships to Disclose
 
Nathalie Aladjidi
No Relationships to Disclose
 
Arnauld Verschuur
No Relationships to Disclose
 
Celine Icher
No Relationships to Disclose
 
Minckes Odile
No Relationships to Disclose
 
Nicolas Sirvent
No Relationships to Disclose
 
Gudrun Schleiermacher
No Relationships to Disclose
 
Nathalie Auger
No Relationships to Disclose
 
Etienne Lonchamp
No Relationships to Disclose
 
Celine Mahier - Ait Oukhatar
Research Funding - Pfizer (Inst)
 
Marie-Cecile Le Deley
No Relationships to Disclose
 
Marta Jimenez
Research Funding - Pfizer (Inst)
 
Natalie Hoog Labouret
Employment - Amgen (I)
Leadership - Amgen (I)
Stock and Other Ownership Interests - Amgen (I)